ONMD OneMedNet Corporation

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 20, 2023

 

ONEMEDNET CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware		001-40386		86-2076743
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification Number)

 

6385 Old Shady Oak Road, Suite 250

Eden Prairie, MN 55344

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: 800-918-7189

 

Data Knights Acquisition Corp.

Unit G6, Frome Business Park, Manor Road

Frome, United Kingdom, BA11 4FN

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

	☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
	☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
Class A Common Stock, $0.0001 par value per share		ONMD		The Nasdaq Stock Market LLC
Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share		ONMDW		The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 7.01 Regulation FD Disclosure.

 

On October 20, 2023, OneMedNet Corporation (the “Company”) issued a press release to announce its Technical Exhibit during the Radiological Society of North America’s (“RSNA”) 2023 Annual Meeting from November 26 - 30, 2023 at McCormick Place in Chicago. The press release is attached hereto as Exhibit 99.1 and incorporated herein by this reference.

 

The information contained in the press release attached hereto is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.		Description
99.1		Press Release dated November 20, 2023
104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	ONEMEDNET CORPORATION
Date: November 22, 2023
	By:	/s/ Paul J. Casey
	Name:	Paul J. Casey
	Title:	Chief Executive Officer

 

 

 

Exhibit 99.1

 

 

OneMedNet Announces Participation as an Exhibitor in the AI Showcase During the RSNA 2023 Annual Meeting

 

Minneapolis, MN – November 20, 2023, OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of regulatory-grade imaging Real World Data (“RWD”), today announced its Technical Exhibit during the Radiological Society of North America’s (“RSNA”) 2023 Annual Meeting from November 26 - 30, 2023 at McCormick Place in Chicago. OneMedNet’s senior team will be on-site to display OneMedNet’s iRWD™ solution via the Artificial Intelligence (“AI”) Showcase in the South Hall A, Level 3, Exhibit Booth #4669. To learn more about OneMedNet and their Real World Data Capabilities, please visit www.onemednet.com.

 

The 2023 RSNA Meeting, titled “RSNA 2023: Leading Through Change” is the largest radiology conference in the U.S. and features the latest in CT, MRI, AI, 3D printing and other imaging modalities. OneMedNet’s iRWD™ solution aggregates clinical imaging data and, through the use of advanced technology, securely anonymizes images to provide its network partners with the foundation to advance research and development protocols and diagnostics in the life sciences field.

 

About the RSNA Annual Meeting

 

RSNA promotes excellence in patient care and health care delivery through education, research and technologic innovation. RSNA is the world’s leading professional radiology organization providing the expertise, practical use and distinct tools needed for the ethical application of AI technology in medical imaging, which aligns with OneMedNet’s unwavering clinical imaging practice and its iRWD™ solution. RSNA 2023 will connect the international radiology community of medical technology professionals, clinicians, students and its diverse attendee participation by providing the latest in AI research, education and technological advances. See 2023 RSNA Meeting and registration information at www.rsna.org.

 

About OneMedNet Corporation

 

OneMedNet was the first company to trademark a RWD offering through its OneMedNet iRWD™ solution that utilizes AI to securely de-identify, search, and curate imaging data for the benefit of its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet integrates AI and other digital technologies into their existing development processes to enhance data anomaly detection, standardization, and quality checking at the pre-processing stage. AI offers OneMedNet’s partners and customers the ability to increase meaningful Real World Evidence output, decrease time to insights, and make the most of the available vast data sources.

 

The OneMedNet iRWD network consists of more than 200 healthcare systems and providers. Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing its proven OneMedNet iRWD™ solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements. For more information, please visit www.onemednet.com.

 

Investor Contact:

 

Shannon Devine

MZ Group North America

203-741-8811

ONMD@mzgroup.us

 

Source: OneMedNet

 

 

v3.23.3

Cover	Nov. 20, 2023
Document Type	8-K
Amendment Flag	false
Document Period End Date	Nov. 20, 2023
Entity File Number	001-40386
Entity Registrant Name	ONEMEDNET CORPORATION
Entity Central Index Key	0001849380
Entity Tax Identification Number	86-2076743
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	6385 Old Shady Oak Road
Entity Address, Address Line Two	Suite 250
Entity Address, City or Town	Eden Prairie
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55344
City Area Code	800
Local Phone Number	918-7189
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Class A Common Stock, $0.0001 par value per share
Title of 12(b) Security	Class A Common Stock, $0.0001 par value per share
Trading Symbol	ONMD
Security Exchange Name	NASDAQ
Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
Title of 12(b) Security	Redeemable Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
Trading Symbol	ONMDW
Security Exchange Name	NASDAQ

---